Ceptur Therapeutics, Inc. is a private biotechnology company headquartered in Hillsborough, New Jersey, focused on developing targeted oligonucleotide therapeutics.
Subscribe to see Ceptur Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ceptur Therapeutics, Inc. is a biotechnology company headquartered in Hillsborough, United States. Its most recent funding round raised $21.5M in December 2021. Xcout tracks 9 named people at Ceptur Therapeutics, Inc., including Michał Walczak (Chief Executive Officer, Chief Scientific Officer).
As of 16 November 2026. Source: Xcout Intel.
3 more named people on record for Ceptur Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $21.5M | — | |
| Series A | $75M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Ceptur Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
miRecule, Inc. is a biotechnology company headquartered in Gaithersburg, Maryland, focused on developing RNA therapeutics.
CereCura Nanotherapeutics Inc. is a biotechnology company established in 2022 and located in Vancouver, British Columbia, focused on developing RNA therapeutics.
Creyon Bio is a biotechnology organization that engineers RNA-based and oligonucleotide medicines designed to enable tissue-specific delivery with improved safety and efficacy.
NextRNA Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts. The company specializes in developing RNA-directed therapeutics to target novel classes of RNA.
Aptadir Therapeutics is a biotechnology company based in Milan, Italy, specializing in the development of RNA inhibitor-based therapeutics. The firm focuses on creating novel treatments for intractable cancers and genetic disorders.
Rgenta Therapeutics, Inc. is a biotechnology research company headquartered in Woburn, Massachusetts, that focuses on unlocking the therapeutic potential of disease-relevant RNA targets.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Ceptur Therapeutics, Inc.? Suggest a correction · Work at Ceptur Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.